Evidence map›Paper›PMID 40144833›Full record

ArticleJHLT open2025

Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients.

Elisabeth Ng, Shanal Kumar, Eldho Paul, Daniel Bennett, Luisa Rosi, Louise Fuller, Lauren Chiu, Shoshana Sztal-Mazer, Steven Ivulich, Greg Snell and 2 more

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elisabeth NgDepartment of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.
Shanal KumarMonash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Eldho PaulMonash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Daniel BennettDepartment of Medicine (Alfred), Monash University, Melbourne, Victoria, Australia.
Luisa RosiDepartment of Medicine (Alfred), Monash University, Melbourne, Victoria, Australia.
Louise FullerDepartment of Medicine (Alfred), Monash University, Melbourne, Victoria, Australia.
Lauren ChiuDepartment of Medicine (Alfred), Monash University, Melbourne, Victoria, Australia.
Shoshana Sztal-MazerDepartment of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.
Steven IvulichDepartment of Pharmacy, Alfred Health, Melbourne, Victoria, Australia.
Greg SnellDepartment of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
Leon A BachDepartment of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.
Kathryn L HackmanDepartment of Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As life expectancy following lung transplantation (LT) improves, vulnerability to glucocorticoid-induced osteoporotic fractures is increased. Our institution offers LT recipients protocolized antiresorptive therapy, with zoledronic acid (ZA) used first line. Methods: Adults who underwent LT from January 2012 to December 2018 and survived at least 6 months were retrospectively studied. Coprimary outcomes were incidence, prevalence, and predictors of osteoporotic fractures and major osteoporotic fractures post-LT. Results: Four hundred and five LT recipients (41% female, median age 59 years) had a median follow-up of 4.9 years (interquartile range 3.4-6.7). Osteoporotic fracture prevalence was 12% ( Conclusion: LT recipients receiving protocolized antiresorptive treatment post-LT had a low incidence of osteoporotic fracture.

Indexed as

antiresorptivebonefracturelung transplantationmortalityosteoporosis

Identifiers

PMID40144833
PMCPMC11935502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.